298 related articles for article (PubMed ID: 34244432)
21. PD-L1 Mediates Dysfunction in Activated PD-1
Concha-Benavente F; Kansy B; Moskovitz J; Moy J; Chandran U; Ferris RL
Cancer Immunol Res; 2018 Dec; 6(12):1548-1560. PubMed ID: 30282672
[TBL] [Abstract][Full Text] [Related]
22. Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization.
Chung DC; Garcia-Batres CR; Millar DG; Wong SWY; Elford AR; Mathews JA; Wang BX; Nguyen LT; Shaw PA; Clarke BA; Bernardini MQ; Sacher AG; Crome SQ; Ohashi PS
J Immunol; 2024 Jun; 212(12):1904-1912. PubMed ID: 38668728
[TBL] [Abstract][Full Text] [Related]
23. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Gao Y; Souza-Fonseca-Guimaraes F; Bald T; Ng SS; Young A; Ngiow SF; Rautela J; Straube J; Waddell N; Blake SJ; Yan J; Bartholin L; Lee JS; Vivier E; Takeda K; Messaoudene M; Zitvogel L; Teng MWL; Belz GT; Engwerda CR; Huntington ND; Nakamura K; Hölzel M; Smyth MJ
Nat Immunol; 2017 Sep; 18(9):1004-1015. PubMed ID: 28759001
[TBL] [Abstract][Full Text] [Related]
24. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
25. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.
Tang L; Peng H; Zhou J; Chen Y; Wei H; Sun R; Yokoyama WM; Tian Z
J Autoimmun; 2016 Feb; 67():29-35. PubMed ID: 26422992
[TBL] [Abstract][Full Text] [Related]
26. STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Lu S; Concha-Benavente F; Shayan G; Srivastava RM; Gibson SP; Wang L; Gooding WE; Ferris RL
Oral Oncol; 2018 Mar; 78():186-193. PubMed ID: 29496049
[TBL] [Abstract][Full Text] [Related]
27. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.
Srivastava RM; Trivedi S; Concha-Benavente F; Gibson SP; Reeder C; Ferrone S; Ferris RL
Clin Cancer Res; 2017 Feb; 23(3):707-716. PubMed ID: 27496866
[TBL] [Abstract][Full Text] [Related]
28. A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.
Van Acker A; Gronke K; Biswas A; Martens L; Saeys Y; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Matthys P; Taghon T; Vandekerckhove B; Plum J; Dunay IR; Diefenbach A; Leclercq G
Cell Rep; 2017 May; 19(7):1431-1443. PubMed ID: 28514662
[TBL] [Abstract][Full Text] [Related]
29. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
30. TGF-β and IL-15 Synergize through MAPK Pathways to Drive the Conversion of Human NK Cells to an Innate Lymphoid Cell 1-like Phenotype.
Hawke LG; Mitchell BZ; Ormiston ML
J Immunol; 2020 Jun; 204(12):3171-3181. PubMed ID: 32332109
[TBL] [Abstract][Full Text] [Related]
31. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
32. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
33. Identification of human cytotoxic ILC3s.
Krabbendam L; Heesters BA; Kradolfer CMA; Spits H; Bernink JH
Eur J Immunol; 2021 Apr; 51(4):811-823. PubMed ID: 33300130
[TBL] [Abstract][Full Text] [Related]
34. Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches.
Asahi T; Abe S; Cui G; Shimba A; Nabekura T; Miyachi H; Kitano S; Ohira K; Dijkstra JM; Miyazaki M; Shibuya A; Ohno H; Ikuta K
Elife; 2023 Jun; 12():. PubMed ID: 37352115
[TBL] [Abstract][Full Text] [Related]
35. [Regulatory T cells and NK cells in cancer patients].
Bergmann C
HNO; 2014 Jun; 62(6):406-14. PubMed ID: 24916348
[TBL] [Abstract][Full Text] [Related]
36. Cancer immunity by tissue-resident type 1 innate lymphoid cells and killer innate-like T cells.
Zhang J; Li AM; Kansler ER; Li MO
Immunol Rev; 2024 May; 323(1):150-163. PubMed ID: 38506480
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Niu M; Combs SE; Linge A; Krause M; Baumann M; Lohaus F; Ebert N; Tinhofer I; Budach V; von der Grün J; Rödel F; Grosu AL; Multhoff G
Radiat Oncol; 2021 Jul; 16(1):141. PubMed ID: 34332614
[TBL] [Abstract][Full Text] [Related]
38. Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies.
Horowitz NB; Mohammad I; Moreno-Nieves UY; Koliesnik I; Tran Q; Sunwoo JB
Front Immunol; 2021; 12():648580. PubMed ID: 33968039
[TBL] [Abstract][Full Text] [Related]
39. Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
Tumino N; Vacca P; Quatrini L; Munari E; Moretta F; Pelosi A; Mariotti FR; Moretta L
Front Immunol; 2019; 10():3140. PubMed ID: 32063901
[TBL] [Abstract][Full Text] [Related]
40. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
